Skip to main content
. 2021 Sep 27;11(10):1015. doi: 10.3390/life11101015

Table 2.

Panels of SARS-CoV-2 positive (N = 106) and negative (N = 26) human and veterinary samples tested for validation of the developed assay.

Panel Mutation Identification Method No. Variant Fluorescence
F H T C
Negative N/A 20 N/A - - - -
Positive (A) Obtained prior to the emergence of the target mutations 20 WT + - - -
ViroBOAR Spike 1.0 RT-PCR Kit 4 WT + - - -
21 Alpha + - - +
1 Beta - - + +
SNPsig SARS-CoV-2 (EscapePLEX) 14 Delta + + - -
Positive (B) NGS (Illumina MiSeq) 2 Alpha + - - +
2 Beta - - + +
36 Delta + + - -
1 B.1.1.318 - - + -
Negative (Vet) N/A 3 cats, 3 minks N/A - - - -
Positive (Vet) NGS (Ion Torrent GeneStudio S5) 2 cats WT + - - -
NGS (Illumina MiSeq) 3 minks WT + - - -

+: fluorescence detection in the respective channel; -: absence of fluorescence in the respective channel; F: FAM; H: HEX; T: Texas Red; C: Cy5; N/A: not applicable; NGS: next-generation sequencing; WT: wild type.